Program
PRA-216
A development code. Also written as “Active PRA-216”.
Its studies are mostly in Pulmonary Disease, Chronic Obstructive · Dermatitis, Atopic · Asthma, led by Prana Therapies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Prana Therapies | 33 open or running | phase 2since Nov 17, 2025 | Nov 17, 2025 | Jun 1, 2027phase 2 · NCT07730281 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Nov 17, 2025First study: phase 2 study in AsthmaFirst studyNCT07245368 · 96 planned · Australia, New Zealand
- Jul 23, 2026Phase 2 study in Pulmonary Disease, Chronic ObstructiveNCT07730281 · 40 planned · Australia
- Sep 3, 2026Phase 2 study in Dermatitis, AtopicNCT07810777 · 39 planned · Australia, New Zealand
Ahead
- Jun 1, 2027Primary completion: phase 2 study in Pulmonary Disease, Chronic ObstructiveNCT07730281
- Sep 30, 2027Primary completion: phase 2 study in Dermatitis, AtopicNCT07810777
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07810777Dermatitis, Atopic · Australia, New Zealand | 2 | Recruiting | Sep 30, 2027 | 39 |
| NCT07730281Pulmonary Disease, Chronic Obstructive · Australia | 2 | Recruiting | Jun 1, 2027 | 40 |
| NCT07245368Asthma · Australia, New Zealand | 2 | Recruiting | Oct 1, 2026 | 96 |
How it is read
Names in the registry
- “PRA-216”, 2 entries
- “Active PRA-216”, 1 entry
Codes read as this program: PRA216.
Conditions, from the studies’ own filings
- Pulmonary Disease, Chronic Obstructive, 1 study
- Dermatitis, Atopic, 1 study
- Asthma, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.